SIGNIFICANT CONCENTRATIONS (Details) - USD ($) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2017 |
Dec. 31, 2016 |
Dec. 31, 2015 |
|
SIGNIFICANT CONCENTRATIONS | |||
Accounts receivable | $ 0 | $ 0 | |
Sales | Customer concentration risk | BerGenBio | |||
SIGNIFICANT CONCENTRATIONS | |||
Concentration risk as a percentage of revenue | 74.00% | 18.00% | |
Sales | Customer concentration risk | Third Party | |||
SIGNIFICANT CONCENTRATIONS | |||
Concentration risk as a percentage of revenue | 26.00% | 12.00% | |
Sales | Customer concentration risk | Bristol-Myers Squibb Company | |||
SIGNIFICANT CONCENTRATIONS | |||
Concentration risk as a percentage of revenue | 82.00% | 60.00% | |
Sales | Customer concentration risk | Aclaris | |||
SIGNIFICANT CONCENTRATIONS | |||
Concentration risk as a percentage of revenue | 28.00% |
X | ||||||||||
- Definition Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|